Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry.
Roman Goff, Morgan Smith, Sabrina Islam, Sue Sisley, Jonathan Ferguson, Scott Kuzdzal, Sunil Badal, Arun Babu Kumar, Uma Sreenivasan, Kevin A Schug
Analytica Chimica Acta February 1, 2024 DOI: 10.1016/j.aca.2023.342161 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Method development and comparative analysis Peer reviewed |
|---|---|
| Sample size | 15 |
| Population | Five strains of dried Psilocybe cubensis mushrooms |
| Topics | Psilocybin |
| Keywords | Extraction Indoleamine Potency Tryptamine Psychedelics hallucinogens Entheogens Psychoactive substances Psilocybe Compound testing Chemical testing |
| Citations | 29 |
| Key points | The Creeper strain had the highest average total psilocybin and psilocin concentration at 1.36% (w/w), and the Thai Cubensis strain had the lowest at 0.879% (w/w). |
Abstract
A method for clinical potency determination of psilocybin and psilocin in hallucinogenic mushroom species Psilocybe cubensis was developed using liquid chromatography with tandem mass spectrometry (LC-MS/MS). Five strains of dried, intact mushrooms were obtained and analyzed: Blue Meanie, Creeper, B-Plus, Texas Yellow, and Thai Cubensis. An extraction protocol was developed; this included an evaluation of sample milling technique, extraction solvents, and recovery/stability. Reversed phase chromatography on fused-core particle phases was developed for the determination of the two analytes using internal standard calibration with deuterated isotopologues of each analyte. The separation takes less than 5 min. Matrix effects were investigated by comparing signal response of calibration samples in neat solution and several mushroom matrices; no significant matrix effects were observed. The limit of detection for psilocybin was 1.5 ng/mL (1.5 pg on-column; 300 ng/g mushroom) and for psilocin was 0.15 ng/mL (0.15 pg on-column; 30 ng/g mushroom) using a Shimadzu LCMS-8050 triple quadrupole mass spectrometer. Assessment of the accuracy and precision of the method indicated percent error and RSD were <6 % at all concentration levels. Three whole, intact mushrooms from each strain were analyzed individually to obtain average content differences both between strains and between mushrooms of the same strain. From most to least potent, the study found that the average total psilocybin and psilocin concentrations for the Creeper, Blue Meanie, B+, Texas Yellow, and Thai Cubensis strains were 1.36, 1.221, 1.134, 1.103, and 0.879 % (w/w), respectively. A subset of these mushrooms was also tested in a separate non-affiliated laboratory, and the results were comparable between the two laboratories. Results from the secondary laboratory showed improved precision when multiple mushrooms were homogenized together, prior to extraction.
Citations in the library
Cited by 24
- Psychedelic risks and benefits: A cross-sectional survey study. Journal of Psychopharmacology May 1, 2025
- Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications Pharmaceuticals March 7, 2025
- Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps Journal of Fungi January 28, 2025
- Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis Mushrooms ACS Omega July 10, 2025
- Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives Pharmaceuticals July 1, 2025
and 19 more in the library
Cites 8
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. New England Journal of Medicine November 3, 2022
- The pharmacology of psilocybin Addiction Biology October 1, 2002
- Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up Journal of Psychopharmacology February 1, 2022
- Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin Journal of Natural Products February 20, 2020
and 3 more in the library